Last reviewed · How we verify
NCT05446766
Feasibility Evaluation of a Self-guided Exposure-based Digital Intervention for Health Anxiety
NA trial testing Self-guided Exposure-based Digital Intervention for Health Anxiety in Illness Anxiety Disorder in 25 participants. Completed in 29 March 2023.
29 March 2023
Quick facts
| Lead sponsor | Karolinska Institutet |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 25 |
| Start date | 6 September 2022 |
| Primary completion | 29 March 2023 |
| Estimated completion | 29 March 2023 |
| Sites | 1 location across Sweden |
Drugs / interventions tested
- Self-guided Exposure-based Digital Intervention for Health Anxiety
Conditions studied
- Illness Anxiety Disorder — all drugs for Illness Anxiety Disorder →
- Somatic Symptom Disorder — all drugs for Somatic Symptom Disorder →
Sponsor
Karolinska Institutet
Who can join
18 and older, any sex, with Illness Anxiety Disorder or Somatic Symptom Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study investigates the feasibility and preliminary efficacy of a self-guided, exposure-based intervention for individuals who suffer from severe health anxiety. The study is a prospective single-group study based at Karolinska Institutet, Stockholm, Sweden, where 20-25 adults with DSM-5 Illness anxiety disorder or Somatic symptom disorder are enrolled in 8 weeks of unguided exposure-based treatment via the Internet. Outcomes include self-reported health anxiety symptoms, credibility and expectancy, adherence to the treatment protocol, client satisfaction, and negative events.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Brief digital self-care intervention for health anxiety in a Swedish Medical University Clinic: a prospective single-group feasibility study.
Österman S, Hentati A, Forsell E, Axelsson E, et al · · 2023 · cited 1× · PMID 38135329 · DOI 10.1136/bmjopen-2023-077376
Verify or expand the search:
- PubMed search for NCT05446766
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Illness Anxiety Disorder
Currently open trials in the same condition.
- NCT03918577 — Caloric Vestibular Stimulation for Modulation of Insight in Obsessive-Compulsive Spectrum Disorders · NA · recruiting
- NCT04899687 — Study of Dextromethorphan in OCD and Related Disorders · Phase 2 · recruiting
Other Karolinska Institutet trials
Trials by the same sponsor.
- NCT06359262 — Evaluating the Hope@School Prevention Program · NA · not yet recruiting
- NCT07289490 — Bilateral vs Unilateral Inguinal Hernia Repairs With an Asymptomatic Inguinal Hernia in Bilateral Hernias · NA · not yet recruiting
- NCT06894264 — Emotion Processing and Regulation in People With Intellectual Disability · NA · not yet recruiting
- NCT07494266 — Safety of a Healthy Plant-based Diet With Higher Potassium Content, Compared to a Healthy Plant-based Diet With Limited · NA · not yet recruiting
- NCT07442032 — Cardiovascular Phenotypes in Sepsis · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05446766 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Karolinska Institutet
- Last refreshed: 10 October 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05446766.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing